Scienture Holdings, Inc. (Nasdaq: SCNX) announced a securities purchase agreement with institutional investors for 3,225,000 shares of common stock.
The offering price is $1.20 per share, with expected gross proceeds of approximately $3.9 million.
Maxim Group LLC is the sole placement agent for this offering.
Offering Details
3,225,000 shares of common stock at $1.20 per share
- The offering is expected to provide additional capital for Scienture Holdings, Inc.'s pharmaceutical operations and product development.
- This move indicates the Company's focus on enhancing value through novel specialty products.
The successful completion of this offering will strengthen Scienture Holdings, Inc.'s financial position and support its strategic objectives in pharmaceutical development and market presence.